Valuation Repligen Corporation Deutsche Boerse AG
Stocks
RGN
US7599161095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
07:03:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 152.75 EUR | +2.17% |
|
+6.30% | +9.77% |
| 07-29 | Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008. | CI |
| 07-29 | Tranche Update on Repligen Corporation's Equity Buyback Plan announced on December 7, 2023. | CI |
Company Valuation: Repligen Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,643 | 9,401 | 10,039 | 8,064 | 9,224 | 10,222 | - | - |
| Change | - | -35.8% | 6.78% | -19.67% | 14.38% | 10.82% | - | - |
| Enterprise Value (EV) 1 | 14,405 | 9,062 | 9,357 | 7,833 | 9,200 | 9,989 | 9,815 | 9,600 |
| Change | - | -37.09% | 3.26% | -16.29% | 17.46% | 8.57% | -1.74% | -2.19% |
| P/E | 118x | 52.3x | 243x | -313x | 191x | 240x | 105x | 74.4x |
| PBR | 8.67x | 4.92x | 5.09x | 4.09x | 4.38x | 4.7x | 4.38x | 3.97x |
| PEG | - | 1.2x | -3.1x | 2x | -1x | -19.8x | 1x | 1.8x |
| Capitalization / Revenue | 21.8x | 11.7x | 15.7x | 12.7x | 12.5x | 12.4x | 10.5x | 8.99x |
| EV / Revenue | 21.5x | 11.3x | 14.6x | 12.3x | 12.5x | 12.1x | 10.1x | 8.45x |
| EV / EBITDA | 62.5x | 36.7x | 73.1x | 66.8x | 65.6x | 58.5x | 44.2x | 33.3x |
| EV / EBIT | 66.9x | 39x | 99.2x | 95.4x | 90.4x | 76.4x | 56.2x | 40.7x |
| EV / FCF | 277x | 104x | 120x | 52.3x | 98x | 83.3x | 67x | 48.2x |
| FCF Yield | 0.36% | 0.96% | 0.83% | 1.91% | 1.02% | 1.2% | 1.49% | 2.08% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.24 | 3.24 | 0.74 | -0.46 | 0.86 | 0.756 | 1.73 | 2.435 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 670.5 | 801.5 | 638.8 | 634.4 | 738.3 | 827 | 969.2 | 1,137 |
| EBITDA 1 | 230.5 | 246.9 | 128 | 117.3 | 140.3 | 170.9 | 222.2 | 288 |
| EBIT 1 | 215.2 | 232.2 | 94.29 | 82.08 | 101.8 | 130.8 | 174.7 | 235.9 |
| Net income 1 | 128.3 | 186 | 41.58 | -25.51 | 48.89 | 41.92 | 98.84 | 141.2 |
| Net Debt 1 | -237.8 | -339.1 | -681.9 | -231.8 | -23.81 | -233.7 | -407.3 | -621.9 |
| Reference price 2 | 264.84 | 169.31 | 179.80 | 143.94 | 163.86 | 181.13 | 181.13 | 181.13 |
| Nbr of stocks (in thousands) | 55,289 | 55,524 | 55,832 | 56,027 | 56,291 | 56,436 | - | - |
| Announcement Date | 17/02/22 | 22/02/23 | 21/02/24 | 20/02/25 | 24/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.46x | 4.49x | 17.25x | 2.2% | 202B | |
| 21.15x | 3.63x | 12.76x | 3.19% | 119B | |
| 17.42x | 0.2x | 12.74x | 0.75% | 60.69B | |
| 30.37x | 7.55x | 19.28x | 1.31% | 52.38B | |
| 37x | 3.53x | 12.12x | 2.04% | 52.3B | |
| 37.01x | 6.52x | 20.46x | -.--% | 34.85B | |
| 44.97x | 1.28x | 11.71x | 0.17% | 30.06B | |
| 41.17x | 7.21x | 25.89x | 0.26% | 24.85B | |
| 19.84x | 3.06x | 11.16x | 1.45% | 23.84B | |
| Average | 31.38x | 4.16x | 15.93x | 1.26% | 66.7B | |
| Weighted average by Cap. | 29.99x | 4.08x | 15.65x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RGEN Stock
- RGN Stock
- Valuation Repligen Corporation
Select your edition
All financial news and data tailored to specific country editions
